Avidity Biosciences (RNA) Other Gross PP&E Adjustments: 2019-2025

Historic Other Gross PP&E Adjustments for Avidity Biosciences (RNA) over the last 6 years, with Sep 2025 value amounting to -$20.9 million.

  • Avidity Biosciences' Other Gross PP&E Adjustments fell 299.91% to -$20.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.1 million, marking a year-over-year increase of 70.05%. This contributed to the annual value of $6.6 million for FY2024, which is 193.12% up from last year.
  • As of Q3 2025, Avidity Biosciences' Other Gross PP&E Adjustments stood at -$20.9 million, which was down 180.67% from $25.9 million recorded in Q2 2025.
  • In the past 5 years, Avidity Biosciences' Other Gross PP&E Adjustments ranged from a high of $25.9 million in Q2 2025 and a low of -$20.9 million during Q3 2025.
  • Over the past 3 years, Avidity Biosciences' median Other Gross PP&E Adjustments value was $6.6 million (recorded in 2024), while the average stood at $5.5 million.
  • As far as peak fluctuations go, Avidity Biosciences' Other Gross PP&E Adjustments crashed by 491.01% in 2021, and later surged by 884.63% in 2023.
  • Quarterly analysis of 5 years shows Avidity Biosciences' Other Gross PP&E Adjustments stood at -$7.9 million in 2021, then fell by 1.02% to -$8.0 million in 2022, then rose by 10.94% to -$7.1 million in 2023, then skyrocketed by 193.12% to $6.6 million in 2024, then slumped by 299.91% to -$20.9 million in 2025.
  • Its Other Gross PP&E Adjustments was -$20.9 million in Q3 2025, compared to $25.9 million in Q2 2025 and $19.5 million in Q1 2025.